# Antimicrobial Stewardship in Canine Diarrhea: When Antibiotics Are Not the Answer
## Key Takeaways
- The majority of acute canine diarrhea cases are self-limiting and non-bacterial, resolving with supportive care alone, rendering antimicrobial therapy unnecessary and potentially harmful due to microbiome disruption and resistance selection.
- Antimicrobial therapy is indicated only in cases with evidence of bacterial infection or a significant risk thereof, characterized by objective clinical signs such as fever, marked lethargy, severe hemorrhagic diarrhea, or suspected sepsis, rather than diarrhea alone.
- Fecal diagnostics, including fecal culture and susceptibility testing, are not first-line interventions for uncomplicated acute diarrhea; they are reserved for refractory, recurrent, or outbreak scenarios, or when specific pathogens with treatment implications are suspected.
- Dietary management, typically involving a highly digestible diet or a short fast followed by gradual reintroduction, and probiotics, which may reduce duration but not prevent diarrhea, are key components of supportive care.
- The decision to use antimicrobials should be guided by a structured diagnostic framework and disease severity thresholds, mirroring principles from production animal medicine, to reserve antibiotics for genuine clinical need and mitigate antimicrobial resistance risks.
- Documentation of the antimicrobial decision-making process, including the rationale for both prescribing and withholding antibiotics, is critical for clinical continuity, stewardship auditing, and adherence to professional guidance from organizations like the AVMA.
---
Acute diarrhea is one of the most frequent presentations in small animal practice, and it is also one of the most common indications for antimicrobial prescription in dogs. The clinical reflex to reach for an antibiotic when faced with fecal urgency, mucus, or hematochezia is understandable, but it is rarely supported by evidence. Most cases of acute canine diarrhea are self-limiting, and the indiscriminate use of antimicrobials in these patients carries measurable risks: disruption of the intestinal microbiome, selection of resistant commensals, and the potential for adverse drug reactions.
This article provides a diagnostic framework for the practicing veterinarian to distinguish the majority of dogs with diarrhea that will resolve with supportive care alone from the minority that require antimicrobial therapy. It covers the pathophysiology of acute diarrhea, the limitations of fecal diagnostics, the role of probiotics and dietary management, and the specific clinical scenarios in which antibiotics are genuinely indicated. The reader will finish with a practical decision pathway that prioritizes patient welfare and antimicrobial stewardship without compromising outcomes.
The principles discussed here align with broader professional guidance on judicious antimicrobial use published by the [American Veterinary Medical Association](https://www.avma.org/resources-tools/one-health/antimicrobial-use-and-antimicrobial-resistance), which emphasizes that antimicrobial therapy should be reserved for patients with evidence of bacterial infection or significant risk of developing one. The same logic that has driven stewardship efforts in livestock medicine, where objective disease severity thresholds reduce unnecessary antimicrobial exposure, applies equally to companion animal practice.
## At a Glance
| Parameter | Clinical Decision Point |
|---|---|
| First 48 hours of uncomplicated acute diarrhea | Supportive care, no antimicrobials |
| Fever, severe hemorrhagic diarrhea, or suspected sepsis | Antimicrobial therapy indicated |
| Fecal culture | Reserve for refractory, recurrent, or outbreak cases |
| Probiotics | May reduce duration, no evidence for prevention |
| Dietary management | Highly digestible diet or short fast, then gradual reintroduction |
| Antimicrobial resistance risk | Every prescription selects for resistance in the gut microbiome |
| Zoonotic pathogens | Consider culture when immunocompromised humans are in the household |
## Pathophysiology of Acute Canine Diarrhea
The intestinal epithelium maintains a dynamic barrier between the luminal contents and the systemic circulation. Disruption of this barrier, whether by dietary indiscretion, stress, viral infection, or parasite burden, leads to increased permeability, altered fluid secretion, and reduced absorptive capacity. The result is diarrhea. In most cases, the inciting cause is transient and the epithelium repairs itself within days.
The majority of acute diarrhea in dogs is non-inflammatory and non-infectious. Dietary indiscretion, sudden diet change, and scavenging behavior account for a substantial proportion of presentations. Viral pathogens, particularly canine parvovirus in unvaccinated puppies and canine coronavirus, can cause significant enteritis, but these are specific diagnoses with distinct clinical features. Bacterial pathogens such as *Salmonella*, *Campylobacter*, and enterotoxigenic *Escherichia coli* are identified in a minority of canine diarrhea cases, and their presence in feces does not automatically establish causation.
The distinction between inflammatory and non-inflammatory diarrhea is central to antimicrobial decision-making. Inflammatory diarrhea, characterized by fever, hematochezia, and systemic signs, suggests mucosal invasion or toxin production and may warrant antimicrobial therapy. Non-inflammatory diarrhea, characterized by normal appetite, absence of fever, and mild clinical signs, reflects a secretory or osmotic process that antibiotics will not correct.
## The Microbiome and Antimicrobial Disruption
The canine intestinal tract harbors a complex microbial community that contributes to nutrient metabolism, immune regulation, and colonization resistance against pathogens. Antimicrobial administration disrupts this community, often for weeks after a single course. The clinical consequences of this disruption include antibiotic-associated diarrhea, increased susceptibility to subsequent enteric infections, and the propagation of antimicrobial resistance genes within the gut reservoir.
The relationship between antimicrobial use in animals and resistance in human pathogens is well documented. A landmark investigation traced a ceftriaxone-resistant *Salmonella enterica* serotype Typhimurium infection in a child to an indistinguishable isolate from cattle during a local outbreak, demonstrating direct transmission of a resistant pathogen from livestock to a human patient. While this example involves cattle, the principle applies to companion animals: resistant organizms selected in the canine gut can be shed into the environment and pose a risk to household members. The [World Organization for Animal Health](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) terrestrial animal health standards recognize this interspecies transmission risk and call for prudent antimicrobial use across all animal species.
## Why Antibiotics Fail in Non-Bacterial Diarrhea
Antimicrobials are effective only against susceptible bacteria. In viral diarrhea, parasitic diarrhea, dietary indiscretion, and inflammatory bowel disease, antibiotics have no direct therapeutic target. The perceived benefit of "covering" these cases with a broad-spectrum agent is illusory. The drug does not shorten the disease course, and it introduces the harms of microbiome disruption and resistance selection without any countervailing benefit.
The concept of a disease severity treatment threshold, developed in calf diarrhea research, provides a useful model for canine practice. In that framework, antimicrobials are applied only when clinical severity crosses a defined threshold, instead of as a reflexive response to diarrhea itself. Survey data from dairy producers show that objective thresholds can substantially reduce antimicrobial use without compromising outcomes. The same logic translates directly to canine diarrhea: define the clinical features that genuinely warrant antimicrobial therapy, and withhold antibiotics below that threshold.
## When Antimicrobials Are Genuinely Indicated
Specific clinical scenarios justify antimicrobial therapy in canine diarrhea. These include parvoviral enteritis with suspected secondary bacterial translocation, hemorrhagic gastroenteritis with systemic inflammatory response syndrome, suspected bacterial peritonitis, and diarrhea in immunocompromised patients. In each case, the decision rests on evidence of bacterial invasion or systemic involvement, not on the presence of diarrhea alone.
Fever, marked lethargy, severe hemorrhagic diarrhea, and neutrophilia with a left shift are objective indicators of systemic inflammation. A dog with these findings may have bacterial translocation across a compromised mucosal barrier, and antimicrobial therapy is appropriate while diagnostic testing proceeds. The choice of agent should follow current formulary guidance, and the [FDA Center for Veterinary Medicine](https://www.fda.gov/animal-veterinary) provides regulatory information on approved drugs and labeling that should be consulted before prescribing.
## The Diagnostic Sequence: Separating Self-Limiting From Serious Disease
The first decision point in any diarrheic dog is not whether to prescribe an antimicrobial, but whether the patient requires hospitalization, intensive monitoring, or immediate intervention. A focused history and physical examination will stratify most patients into one of three tracks: outpatient supportive care, in-hospital monitoring without antimicrobials, or immediate antimicrobial therapy with or without additional diagnostics.
Historical features that shift the index of suspicion toward a bacterial or protozoal etiology include recent acquisition from a shelter or breeding facility, exposure to raw meat diets, known contact with wildlife feces, and failure to respond to a 48 to 72 hour trial of supportive care. The presence of hematochezia alone does not distinguish inflammatory from infectious diarrhea, nor does it predict antimicrobial responsiveness. Fever, marked lethargy, and abdominal pain out of proportion to the diarrheal volume are more concerning findings that warrant a minimum database including a complete blood count, serum biochemistry panel, and abdominal imaging.
The fecal examination remains the most immediately useful laboratory test. Direct smear, fecal flotation, and a sensitive antigen test for parvovirus should be performed in any patient with vomiting, lethargy, or hemorrhagic diarrhea, particularly if the vaccination history is incomplete. A negative parvovirus test does not exclude infection in the earliest phase of disease, and repeat testing or PCR may be warranted when clinical suspicion remains high. Fecal cytology for bacterial populations has poor predictive value for antimicrobial selection and should not be used as a standalone justification for antibiotic therapy.
## The Fecal Culture Decision
Fecal culture and susceptibility testing are not first-line tests in acute canine diarrhea. The healthy canine colon harbors a dense and diverse bacterial community, and culture of diarrheic feces frequently yields organizms that are commensals or incidental findings. Culture is indicated when there is a specific clinical or epidemiological reason to suspect a pathogen for which antimicrobial therapy would change the outcome, such as Salmonella species in a patient with systemic signs, or when diarrhea persists beyond five to seven days despite appropriate supportive care.
The interpretation of a positive culture requires clinical correlation. Isolation of Salmonella from a diarrheic dog does not mandate antimicrobial therapy, most immunocompetent dogs clear the organizm without treatment, and antimicrobial administration may prolong shedding. The same principle applies to Campylobacter species, which are frequently isolated from both healthy and diarrheic dogs. Antimicrobial therapy for Campylobacter should be reserved for patients with severe or prolonged clinical signs, and the choice of agent should be guided by susceptibility testing where available. The prevalence and resistance profiles of thermophilic Campylobacter species vary substantially by region and production system, as documented in a systematic review of human and animal isolates from sub-Saharan Africa, and local resistance patterns should inform empirical choices when treatment is unavoidable.
Culture becomes more valuable in specific clinical contexts. A dog with hemorrhagic diarrhea and a suspected nosocomial outbreak, a household with multiple affected animals, or a patient with known immunocompromise may justify culture earlier in the diagnostic sequence. In these situations, culture and susceptibility testing should be performed before antimicrobial administration, because prior therapy will suppress growth and may yield false-negative results.
## The Antimicrobial Decision Tree
The decision to administer an antimicrobial to a diarrheic dog should follow a structured pathway instead of a reflexive response to the presence of diarrhea. The following framework applies to dogs with acute diarrhea of less than five days duration in the absence of identifiable toxin exposure.
| Clinical scenario | Antimicrobial indicated? | Rationale and next step |
|---|---|---|
| Mild diarrhea, normal appetite, no vomiting, no fever | No | Outpatient supportive care, recheck in 48 to 72 hours |
| Moderate diarrhea, mild lethargy, no fever, no abdominal pain | No | Supportive care, monitor hydration and appetite |
| Hemorrhagic diarrhea, normal mentation, no fever | No initially | Supportive care with IV fluids, reassess at 24 hours |
| Hemorrhagic diarrhea with fever, marked lethargy, or abdominal pain | Yes | Consider culture before first dose if stable, begin empirical therapy |
| Diarrhea with suspected sepsis, perforation, or peritonitis | Yes | Immediate therapy, address surgical disease |
| Diarrhea persisting beyond 5 to 7 days despite supportive care | Conditional | Culture and susceptibility before therapy |
| Diarrhea in a known immunocompromised patient | Conditional | Lower threshold for culture and therapy |
| Diarrhea with confirmed parvovirus infection | Conditional | Antimicrobials only if sepsis or neutropenia with fever is documented |
The treatment threshold concept, borrowed from production animal medicine, provides a useful mental model. A survey of dairy calf producers defined a disease severity threshold above which producers would normally apply antimicrobials, and found that more selective application was associated with written veterinary protocols and a better understanding of case definitions. The same logic applies in canine practice: the clinician should define, in advance, the clinical findings that would trigger antimicrobial use, and document the reasoning when that threshold is crossed.
## Monitoring Parameters That Guide Therapy
Once the decision is made to withhold antimicrobials, the clinician must define objective parameters that will trigger reassessment. Serial monitoring of hydration status, body weight, urine output, and fecal frequency provides the foundation. A patient that deteriorates despite fluid therapy, develops a fever, or shows progressive abdominal pain requires re-evaluation and a reconsideration of the antimicrobial decision.
The following monitoring parameters are useful in hospitalized patients:
| Parameter | Frequency | What it detects |
|---|---|---|
| Body weight | Every 12 hours | Ongoing fluid losses or inadequate replacement |
| Urine output | Every 6 to 8 hours | Renal perfusion and hydration adequacy |
| Fecal frequency and character | Every 8 hours | Progression or resolution of diarrhea |
| Temperature | Every 8 hours | Development of fever suggesting systemic inflammation |
| Mentation and activity | Every 4 to 6 hours | Deterioration requiring escalation of care |
| Abdominal palpation | Every 8 hours | Pain, distension, or mass effect |
| Packed cell volume and total protein | Every 12 to 24 hours | Hemoconcentration, blood loss, or protein loss |
A patient that remains stable or improves over 48 hours of supportive care is unlikely to benefit from antimicrobial therapy. A patient that worsens, develops fever, or shows evidence of systemic inflammatory response syndrome requires a complete re-evaluation, including blood culture if sepsis is suspected, and antimicrobial therapy should be initiated promptly when the clinical picture supports bacterial invasion.
## Documentation and Stewardship Frameworks
The medical record should document the antimicrobial decision, whether that decision is to prescribe or to withhold. For patients managed without antimicrobials, the record should note the clinical findings that supported conservative management, the monitoring plan, and the specific criteria that would trigger antimicrobial therapy. This documentation serves both clinical continuity and stewardship auditing purposes.
Professional guidance from the AVMA emphasizes that antimicrobial stewardship is a practice-level commitment that includes establishing treatment protocols, reviewing antimicrobial use patterns, and educating all members of the healthcare team. The FDA Center for Veterinary Medicine provides regulatory information on approved drugs, labeling, and extralabel use that should inform prescribing decisions when antimicrobials are indicated. International standards from the World Organization for Animal Health address responsible use of antimicrobial agents in veterinary medicine and provide a framework for national and regional stewardship programs.
The clinician should also recognize that antimicrobial resistance in zoonotic pathogens has direct public health consequences. A documented case of ceftriaxone-resistant Salmonella typhimurium infection in a child was traced to cattle isolates with identical resistance determinants, providing evidence that antimicrobial use in animals can compromise human therapeutic options. This one-health perspective reinforces the importance of every antimicrobial decision made in small animal practice.
## Recognized Complications and Early Detection
The principal complication of antimicrobial overuse in canine diarrhea is selection for resistant commensal and pathogenic bacteria. The zoonotic dimension is not theoretical. A documented case of ceftriaxone-resistant *Salmonella enterica* serotype Typhimurium in a child was traced by molecular typing to an indistinguishable isolate from cattle during a local outbreak, with resistance determinants carried on a conjugative plasmid [FDA CVM regulatory context](https://www.fda.gov/animal-veterinary). The same plasmid-mediated transfer mechanisms operate in canine enteric flora. When a dog receives an unnecessary broad-spectrum agent, the gut becomes a reservoir for resistance genes that can transfer to *Campylobacter*, *Salmonella*, and enterotoxigenic *E. coli* lineages of public health importance [thermophilic *Campylobacter* prevalence and resistance review](https://pubmed.ncbi.nlm.nih.gov/32025233/).
A second complication is prolongation of clinical signs. Antimicrobials that suppress obligate anaerobes delay recolonisation of the colonic mucosa and can convert a 48 hour episode of acute diarrhea into a 7 to 10 day dysbiosis. Early detection relies on serial fecal scoring. If the owner reports that stool consistency has not improved by day 3 of supportive care, the first question is not "which antibiotic" but "was the diagnosis correct and is hydration adequate." A fecal smear for cytology at this point rarely changes management but documents the absence of clostridial spores or leukocytes if the clinician is considering escalation.
A third failure mode is the adverse drug event itself. Metronidazole at high doses can produce central nervous system signs, and fluoroquinolones in growing dogs carry arthropathy risk. These events are often attributed to the primary disease. Early detection requires that the clinician record a baseline neurologic examination and review it if the patient deteriorates after antimicrobial initiation instead of improving.
## Common Errors and Corrective Actions
The most frequent error is treating the fecal appearance instead of the patient. A dog with hemorrhagic diarrhea but normal perfusion, normal mentation, and no abdominal pain on palpation does not meet the severity threshold for antimicrobial therapy in most published stewardship frameworks [dairy calf disease severity treatment thresholds](https://pubmed.ncbi.nlm.nih.gov/27435649/). The corrective action is to write the treatment threshold into the record before prescribing: temperature, heart rate, mucous membrane color, and fecal character at presentation, then recheck at 12 and 24 hours.
A second error is culturing feces from every diarrhoeic dog and treating any organizm that grows. The canine colon harbours *Clostridium perfringens*, *E. coli*, and enterococci as normal inhabitants. A culture result without quantitative significance or clinical correlation invites inappropriate therapy. The corrective action is to restrict culture to dogs with fever, suspected sepsis, hemorrhagic diarrhea with systemic signs, or known exposure to a multidrug-resistant outbreak, and to interpret growth in the context of cytology and clinical severity.
A third error is prescribing a probiotic and an antimicrobial simultaneously and attributing failure to the probiotic. Many commercial products contain organizms susceptible to the prescribed agent. The corrective action is to sequence: complete the antimicrobial course if truly indicated, then introduce the probiotic. Where the evidence base for direct-fed microbials in stressed animals is strongest, it comes from production animal settings where antimicrobials and probiotics are not co-administered [nutritional intervention to enhance intestinal health in weaned pigs](https://pubmed.ncbi.nlm.nih.gov/35990617/).
## Limitations of the Evidence and Divergent Expert Opinion
The evidence base for antimicrobial decisions in canine diarrhea is thinner than in production animal medicine. Controlled trials comparing antimicrobial to placebo for acute canine diarrhea are few, and most published guidance extrapolates from calf and piglet data. In calves, objective disease severity thresholds have been shown to predict which producers apply antimicrobials selectively, but the same thresholds have not been validated in dogs [antimicrobial stewardship disease severity treatment thresholds in calf producers](https://pubmed.ncbi.nlm.nih.gov/27435649/). Expert opinion diverges on whether hemorrhagic diarrhea without systemic signs warrants a short course of metronidazole. Some specialists argue that the risk of clostridial overgrowth justifies treatment, others point to the absence of trial data and the dysbiosis risk. Both positions are defensible, and the clinician should document which rationale applies to the individual case.
A second area of uncertainty is the role of fecal culture in chronic or relapsing diarrhea. Culture identifies organizms but not pathogenicity, and susceptibility testing of commensal flora can mislead. The prudent position is to treat the patient, not the plate, and to reserve culture for cases where a specific pathogen is suspected on epidemiological or cytological grounds.
## Referral, Consultation, and Reporting
Referral to an internal medicine specialist is warranted when diarrhea persists beyond 7 days despite appropriate supportive care, when weight loss or hypoalbuminaemia develops, or when the diagnostic sequence has excluded infectious causes and inflammatory bowel disease, neoplasia, or exocrine pancreatic insufficiency remain in the differential. Specialist consultation is also appropriate before starting immunosuppressive doses of glucocorticoids in a dog with diarrhea of unknown cause.
Laboratory involvement extends beyond fecal culture. Quantitative fecal PCR panels can identify *Giardia*, *Cryptosporidium*, *Salmonella*, and *Campylobacter* with high sensitivity, but a positive PCR does not prove causation. The laboratory should be consulted when a zoonotic pathogen is suspected, because speciation and typing may inform both treatment and public health advice [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/).
Regulatory reporting obligations vary by jurisdiction. Reportable enteric pathogens in dogs include *Salmonella* in some regions and *Brucella canis* in others. The clinician should consult local veterinary authorities and the AVMA stewardship resources for current reporting requirements [AVMA antimicrobial use and stewardship guidance](https://www.avma.org/resources-tools/one-health/antimicrobial-use-and-antimicrobial-resistance). When a multidrug-resistant organizm is isolated from a dog with household contact to young children, immunocompromised adults, or pregnant women, the conversation with the owner must include hygiene measures and the rationale for withholding antimicrobials that would select for further resistance.
| Observation | Likely Cause | Discriminating Check |
|---|---|---|
| Diarrhea persists beyond 72 hours on supportive care | Inadequate fluid therapy, dietary indiscretion ongoing, or missed diagnosis | Recheck hydration status, repeat abdominal palpation, review diet history |
| Worsening hemorrhagic diarrhea with fever | True bacterial enteritis or sepsis | Blood smear, fecal cytology for leukocytes, consider culture and blood pressure measurement |
| Neurologic signs after metronidazole initiation | Metronidazole neurotoxicity | Discontinue drug, reassess in 24 hours, document resolution |
| Positive fecal culture for *E. coli* in stable patient | Commensal growth, not pathogen | Correlate with cytology and systemic signs before treating |
| Owner reports no improvement after probiotic | Probiotic inactivated by concurrent antimicrobial | Sequence administration, verify product viability and strain |
## Frequently Asked Questions
### How Do I Manage Acute Diarrhea When the Owner Demands Antibiotics?
Explain that most acute canine diarrhea is self-limiting and that antimicrobials do not shorten the clinical course in non-bacterial cases. Frame the decision around the physical examination and fecal cytology findings, not owner anxiety. Offer a concrete supportive plan: dietary modification, hydration monitoring, and a recheck appointment in 48 hours. If the owner remains insistent, document the discussion and the clinical rationale for withholding therapy. Professional guidance from the [AVMA on antimicrobial stewardship](https://www.avma.org/resources-tools/one-health/antimicrobial-use-and-antimicrobial-resistance) supports this approach. Reserve antimicrobials for cases meeting the objective criteria described in the diagnostic sequence, such as fever, hemorrhagic diarrhea with systemic signs, or suspected sepsis.
### What Do I Do When Fecal Culture Is Unavailable or Cost-Prohibitive?
Culture is not mandatory for every diarrheic patient. When it is unavailable, rely on clinical severity scoring, fecal cytology, and response to supportive care. Cytology can identify spirochetes, clostridial spores, or inflammatory populations, but these findings alone do not confirm bacterial enteritis. If the patient meets systemic illness criteria and culture is not possible, treat empirically with a narrow-spectrum agent and reassess within 48 hours. Document the limitation in the record. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides guidance on interpreting fecal diagnostics in context. Remember that a negative culture does not exclude a bacterial etiology, and a positive culture does not prove causation, so clinical judgment remains the final arbiter.
### How Does This Framework Apply to Puppies or Immunocompromised Patients?
Young puppies and immunocompromised adults have less reserve and a narrower window before decompensation. The threshold for antimicrobial therapy should be lower, but the diagnostic reasoning remains the same. Parvoviral enteritis requires supportive care, not antibiotics directed at the virus itself, although secondary bacterial translocation may justify antimicrobial coverage in confirmed cases. For puppies with hemorrhagic diarrhea and systemic signs, empirical therapy is reasonable while awaiting diagnostics. The principles of selective antimicrobial use still apply, but the risk-benefit calculation shifts. Cross-species evidence from calf diarrhea research demonstrates that severity-based treatment thresholds can reduce antimicrobial use without compromising outcomes, as shown in a [survey of dairy producers on disease severity treatment thresholds](https://pubmed.ncbi.nlm.nih.gov/27435649/).
### What Records Should I Keep for Antimicrobial Decisions in Diarrhea Cases?
Record the indication, the drug chosen, the dose, the duration, and the recheck plan for every antimicrobial prescription. For cases where antibiotics are withheld, document the examination findings, the differential list, the client discussion, and the planned monitoring interval. This creates a defensible medical record and supports practice-level stewardship audits. The [FDA Center for Veterinary Medicine](https://www.fda.gov/animal-veterinary) provides regulatory context for prescription and extralabel use documentation. Review your diarrhea cases quarterly to identify patterns: how often are antibiotics prescribed, for which severity scores, and what are the outcomes? This audit loop is the practical engine of stewardship.
### How Do I Explain the Stewardship Position to a Referring Veterinarian or Supervisor?
Frame the discussion around case-specific findings instead of policy. Present the physical examination data, the severity score, and the differential list, then explain why antimicrobials were or were not selected. Acknowledge that reasonable clinicians may disagree and invite their input on the monitoring plan. If a supervisor prefers empirical antimicrobials, propose a compromise: initiate therapy only if the patient fails to improve within 48 hours of supportive care. This staged approach preserves clinical safety while reducing unnecessary exposure. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) emphasize that antimicrobial use decisions should be based on clinical need and professional judgment.
### Does the Same Framework Apply to Other Species in My Practice?
The principles transfer, but the thresholds and common etiologies differ. In food animals, production-level considerations and withdrawal periods alter the decision calculus. In swine, enterotoxigenic *E. coli* is a leading driver of antimicrobial use, and nutritional interventions can reduce reliance on drugs, as summarized in a [review of intestinal challenges in weaned pigs](https://pubmed.ncbi.nlm.nih.gov/35990617/). In cattle, calf diarrhea severity scoring has been formalized into treatment thresholds. The core logic, reserve antimicrobials for systemic illness and documented bacterial infection, is universal, but you must adapt the specific criteria to each species' physiology, common pathogens, and regulatory context. Consult species-specific references before applying any framework across species.
## Related Clinical & Scientific Guides
* [Veterinary Formulary Essentials: Navigating Drug References](/knowledge/veterinary-medicine/clinical-pharmacology/veterinary-formulary-essentials-navigating-drug-references)
* [Drug Interactions with Antiepileptic Drugs in Veterinary Patients: Managing Polypharmacy](/knowledge/veterinary-medicine/clinical-pharmacology/drug-interactions-antiepileptic-veterinary)
* [Drug Interactions with Corticosteroids in Veterinary Patients: A Comprehensive Review](/knowledge/veterinary-medicine/clinical-pharmacology/drug-interactions-corticosteroids-veterinary-comprehensive)
## References and Further Reading
- [Board-invited review: recent advances in management of highly stressed, newly received feedlot cattle.](https://pubmed.ncbi.nlm.nih.gov/17085724/). 2007.
- [Enterotoxigenic Escherichia coli infection of weaned pigs: Intestinal challenges and nutritional intervention to enhance disease resistance.](https://pubmed.ncbi.nlm.nih.gov/35990617/). 2022.
- [Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine.](https://pubmed.ncbi.nlm.nih.gov/27218014/). 2016.
- [Prevalence, Risk Factors, and Antimicrobial Resistance Profiles of Thermophilic Campylobacter Species in Humans and Animals in Sub-Saharan Africa: A Systematic Review.](https://pubmed.ncbi.nlm.nih.gov/32025233/). 2020.
- [Understanding antimicrobial stewardship: Disease severity treatment thresholds and antimicrobial alternatives among organic and conventional calf producers.](https://pubmed.ncbi.nlm.nih.gov/27435649/). 2016.
- [Ceftriaxone-resistant salmonella infection acquired by a child from cattle.](https://pubmed.ncbi.nlm.nih.gov/10781620/). 2000.
- [FDA Center for Veterinary Medicine: Animal Drug Information](https://www.fda.gov/animal-veterinary). FDA CVM.
- [AVMA Antimicrobial Use and Stewardship](https://www.avma.org/resources-tools/one-health/antimicrobial-use-and-antimicrobial-resistance). American Veterinary Medical Association.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
## Related Articles
- [Antimicrobial Stewardship in Canine Periodontal Disease: Antibiotic Use in Dentistry](/knowledge/veterinary-medicine/clinical-pharmacology/antimicrobial-stewardship-canine-periodontal)
- [Antibiotic Stewardship in Canine Skin Infections: Choosing Wisely](/knowledge/veterinary-medicine/clinical-pharmacology/antibiotic-stewardship-canine-skin-infections-choosing-wisely)
- [Antimicrobial Stewardship in Canine Postoperative Infections: Prevention and Treatment](/knowledge/veterinary-medicine/clinical-pharmacology/antimicrobial-stewardship-canine-postoperative)
- [Antimicrobial Stewardship in Feline Respiratory Infections: When Antibiotics Are Needed](/knowledge/veterinary-medicine/clinical-pharmacology/antimicrobial-stewardship-feline-respiratory)
- [Antimicrobial Stewardship in Canine Otitis: Culture, Susceptibility, and Topical Therapy](/knowledge/veterinary-medicine/clinical-pharmacology/antimicrobial-stewardship-canine-otitis)
> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.